By: P.T., STA
Salus, a wholesaler of medicines, reported a net profit of EUR 6.8 million for the first nine months of the year, up 56.5% year-on-year, as revenue rose by 14.7% to EUR 292 million.
Salus benefited from a surge in demand for medicines in March, after the coronavirus pandemic was first declared, whereupon demand eased off. The group expects end-year sales to reach EUR 350 million and net profit EUR 5.7 million, slightly less than in 2019.
